BDBM50009152 2-(2-{2-[2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-phenyl-propionylamino)-N*1*-{1-[1-(carbamoylmethyl-carbamoyl)-2-methyl-propylcarbamoyl]-2-methyl-propyl}-succinamide::CHEMBL282943

SMILES: CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)NCC(N)=O

InChI Key: InChIKey=UZDYVPXQTKXZGD-PKNMDTBHSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50009152   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Opioid receptors; mu & delta (Rattus norvegicus (rat))	BDBM50009152 (2-(2-{2-[2-Amino-3-(4-hydroxy-phenyl)-propionylami...) Show SMILES CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)NCC(N)=O Show InChI InChI=1S/C37H53N9O9/c1-19(2)30(36(54)41-18-29(40)49)46-37(55)31(20(3)4)45-35(53)27(17-28(39)48)44-34(52)26(16-22-9-7-6-8-10-22)43-32(50)21(5)42-33(51)25(38)15-23-11-13-24(47)14-12-23/h6-14,19-21,25-27,30-31,47H,15-18,38H2,1-5H3,(H2,39,48)(H2,40,49)(H,41,54)(H,42,51)(H,43,50)(H,44,52)(H,45,53)(H,46,55)/t21-,25-,26-,27-,30-,31-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	0.650	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
National Institute of Environmental Health Sciences Curated by ChEMBL					Assay Description Inhibition of [3H]-DADLE binding to opioid receptor delta in P2 membrane preparation of rat brain				J Med Chem 34: 1350-5 (1991) BindingDB Entry DOI: 10.7270/Q2ZW1MHT
					More data for this Ligand-Target Pair
Mu-type opioid receptor (Rattus norvegicus (rat))	BDBM50009152 (2-(2-{2-[2-Amino-3-(4-hydroxy-phenyl)-propionylami...) Show SMILES CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)NCC(N)=O Show InChI InChI=1S/C37H53N9O9/c1-19(2)30(36(54)41-18-29(40)49)46-37(55)31(20(3)4)45-35(53)27(17-28(39)48)44-34(52)26(16-22-9-7-6-8-10-22)43-32(50)21(5)42-33(51)25(38)15-23-11-13-24(47)14-12-23/h6-14,19-21,25-27,30-31,47H,15-18,38H2,1-5H3,(H2,39,48)(H2,40,49)(H,41,54)(H,42,51)(H,43,50)(H,44,52)(H,45,53)(H,46,55)/t21-,25-,26-,27-,30-,31-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	176	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
National Institute of Environmental Health Sciences Curated by ChEMBL					Assay Description Inhibition of [3H]DAGO binding to trat brain opioid receptor mu in P2 membrane				J Med Chem 34: 1350-5 (1991) BindingDB Entry DOI: 10.7270/Q2ZW1MHT
					More data for this Ligand-Target Pair